Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria

N Engl J Med. 2022 Jul 21;387(3):282. doi: 10.1056/NEJMc2205922.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antimalarials* / therapeutic use
  • Humans
  • Malaria, Vivax* / drug therapy
  • Malaria, Vivax* / prevention & control
  • Plasmodium vivax
  • Primaquine / therapeutic use
  • Recurrence

Substances

  • Antimalarials
  • Primaquine